FAQ

A. Safety, Efficacy, and Benefits

B. Test interpretation and cut-offs

C. Clinical use

D. Biomarkers in Cardiology-8 (BIC-8) Study

E. Copeptin and other blood biomarkers in AMI rule-out

 

A. Safety, Efficacy, and Benefits

 

B. Test interpretation and cut-offs

 

C. Clinical use

 

D. Biomarker in Cardiology-8 (BIC-8) Study

 

E. Copeptin and other blood biomarkers in AMI rule-out

References FAQ Rule-out AMI

Ref-1: Mockel et al.. Eur Heart J 2014; DOI 10.1093/eurheartj/ehu178

Ref-2: Gandhi & Januzzi. Eur Heart J. 2014; DOI 10.1093/eurheartj/ehu211

Ref-3: Lipinski et al. Am J Cardiol 2014;113(9):1581-91.

Ref-4: Schull et al. Ann Emerg Med. 2004;44(6):577-85.

Ref-5: Diercks et al. Ann Emerg Med 2007;50(5):489-96.

Ref-6: Pines et al. Acad Emerg Med 2009;16(7):617-25.

Ref-7: Sprivulis et al. Med J Aust 2006;184(5):208-12.

Ref-8: Guttmann et al. BMJ 2011;342:d2983.

Ref-9: Hamm et al. Eur Heart J 2011;32(23):2999-3054.

Ref-10. Stallone et al. Heart. 2014; DOI 10: 1136/heartjnl-2014-305583

Ref-11: Reichlin et al. J Am Coll Cardiol 2009;54(1):60-8.

Ref-12: Keller et al. J Am Coll Cardiol 2010;55(19):2096-106.

Ref-13: Morgenthaler et al. Clin Chem 2006;52(1):112-9.

Ref-14: Wright. Clin Endocrinol Metab 1978;7(2):351-67.

Ref-15: Goldsmith et al. Clin Pharmacol Ther 1988;44(4):478-81.

Ref-16: Chiodera et al. Acta Endocrinol (Copenh) 1990;123(5):487-92.

Ref-17: Netscher et al. Plast Reconstr Surg 1995;96(3):681-8.

Ref-18: Khan et al. Circulation 2007;115(16):2103-10.

Ref-19: Maisel et al. J Am Coll Cardiol. 2013; 62(2):150-60.

Ref-20: Liebetrau et al. Clin Chem. 2013;59(3):566

thermo scientific applied biosystems invitrogen fisher scientific unity lab service